Anteneh Desalegn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anteneh Desalegn has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Angela Lupattelli
PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
3 shared publications - Alicia Paini
Chemical Safety and Alternative Methods Unit, EURL ECVAM, Directorate F - Health, Consumers and Reference Materials, Joint Research Centre, European Commission, Ispra, Italy
2 shared publications - Andrew Paul Worth
European Commission, Joint Research Centre (JRC), Ispra, Italy
2 shared publications Argelia Castaño
National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
2 shared publications- Asres Berhan
Hawassa University College of Medicine and Health Sciences, Hawassa, Ethiopia
2 shared publications Bart van der Burg
BioDetection Systems BV, Science Park 406, 1098XH, Amsterdam, the Netherlands
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 18, 1-13
Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience
Applying standardized Brighton Collaboration (BC) case definitions retrospectively to heterogeneous real-world data (RWD) is challenging due to inconsistent clinical detail and data structures across settings. To address this, the Vaccine Monitoring Collaboration for Europe (VAC4EU) developed a structured validation pipeline that operationalizes BC case definitions for vaccine safety outcomes in RWD in a harmonized, scalable, and reusable manner. VAC4EU developed a systematic, stepwise approach to validate vaccine safety outcomes. BC case definitions were utilized when available, adapted for RWD as needed, and newly developed for outcomes without an existing BC definition. The approach involves: 1) Critical review and adaptation of BC definition by clinical and RWD experts; 2) Creation of dummy cases based on published reports; 3) Creation of REDCap electronic data collection forms (eDCF) incorporating decision logic to assigned levels of certainty (LOC); 4) Iterative testing of decision logic; and 5) comprehensive training of abstractors with real-time feedback. A dedicated task force assigned reference LOCs for dummy cases. Inter-rater reliability was measured using Fleiss’ kappa (κ) by comparing abstractor LOCs to the reference standard. The pipeline was applied to 16 COVID-19 vaccine safety outcomes, of which 13 had existing BC definition. In total, 78 dummy case descriptions were developed across the outcomes for training of abstractors, and 15 REDCap eDCFs were created. Myocarditis and pericarditis shared an eDCF. Across 33 abstractors, 747 dummy case abstractions were completed. Agreement analysis showed 93 discrepancies (12.4%) and moderate overall concordance (κ = 0.55, across all outcomes), with the lowest for thrombosis with thrombocytopenia syndrome (κ = –0.05). The VAC4EU validation pipeline provides a standardized framework for training and validating vaccine safety outcome in RWD. By adapting BC case definitions and dedicated training of abstractors, we will reduce variability in outcome validation in post-authorization safety studies.
- 1 January 2026
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 18, 1-13
Open AccessHarmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience
Applying standardized Brighton Collaboration (BC) case definitions retrospectively to heterogeneous real-world data (RWD) is challenging due to inconsistent clinical detail and data structures across settings. To address this, the Vaccine Monitoring Collaboration for Europe (VAC4EU) developed a structured validation pipeline that operationalizes BC case definitions for vaccine safety outcomes in RWD in a harmonized, scalable, and reusable manner. VAC4EU developed a systematic, stepwise approach to validate vaccine safety outcomes. BC case definitions were utilized when available, adapted for RWD as needed, and newly developed for outcomes without an existing BC definition. The approach involves: 1) Critical review and adaptation of BC definition by clinical and RWD experts; 2) Creation of dummy cases based on published reports; 3) Creation of REDCap electronic data collection forms (eDCF) incorporating decision logic to assigned levels of certainty (LOC); 4) Iterative testing of decision logic; and 5) comprehensive training of abstractors with real-time feedback. A dedicated task force assigned reference LOCs for dummy cases. Inter-rater reliability was measured using Fleiss’ kappa (κ) by comparing abstractor LOCs to the reference standard. The pipeline was applied to 16 COVID-19 vaccine safety outcomes, of which 13 had existing BC definition. In total, 78 dummy case descriptions were developed across the outcomes for training of abstractors, and 15 REDCap eDCFs were created. Myocarditis and pericarditis shared an eDCF. Across 33 abstractors, 747 dummy case abstractions were completed. Agreement analysis showed 93 discrepancies (12.4%) and moderate overall concordance (κ = 0.55, across all outcomes), with the lowest for thrombosis with thrombocytopenia syndrome (κ = –0.05). The VAC4EU validation pipeline provides a standardized framework for training and validating vaccine safety outcome in RWD. By adapting BC case definitions and dedicated training of abstractors, we will reduce variability in outcome validation in post-authorization safety studies.
- 21 July 2023
- Published by Elsevier in Environmental Pollution
- Vol. 335, 122214
PFAS association with kisspeptin and sex hormones in teenagers of the HBM4EU aligned studies
- 21 July 2023
- Published by Elsevier in Environmental Pollution
- Vol. 335, 122214
PFAS association with kisspeptin and sex hormones in teenagers of the HBM4EU aligned studies
- Open Access
- 2 November 2022
- Published by Elsevier in Environmental Pollution
- Vol. 316 (Pt 1) , 120566
Cross-sectional associations between exposure to per- and polyfluoroalkyl substances and body mass index among European teenagers in the HBM4EU aligned studies
- 2 November 2022
- Published by Elsevier in Environmental Pollution
- Vol. 316 (Pt 1) , 120566
Open AccessCross-sectional associations between exposure to per- and polyfluoroalkyl substances and body mass index among European teenagers in the HBM4EU aligned studies
- Open Access
- 9 July 2022
- Published by Elsevier in Environmental Research
- Vol. 214 (Pt 1) , 113861
Aryl hydrocarbon receptor activity in human breast milk and cryptorchidism: A case-control study within the prospective Norwegian HUMIS cohort
- 9 July 2022
- Published by Elsevier in Environmental Research
- Vol. 214 (Pt 1) , 113861
Open AccessAryl hydrocarbon receptor activity in human breast milk and cryptorchidism: A case-control study within the prospective Norwegian HUMIS cohort
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Aryl Hydrocarbon Receptor Activity in Human Breast Milk and Cryptorchidism. A Casecontrol Study within the Prospective Norwegian Humis Cohort
Background : The aetiology of cryptorchidism remains poorly understood. Exposure to specific endocrine disrupting chemicals are associated with cryptorchidism. A potential mechanism of EDCs may be by impacting estrogen signaling by interacting with aryl hydrocarbon receptor (AhR) activity.Objective : To evaluate whether AhR activity in mothers milk samples is associated with offspring cryptorchidism.Method : We conducted a case-control study based on 199 mother-child pairs (91 cases/108 controls) selected from the prospective Norwegian birth cohort HUMIS, recruited in 2002-2009. We defined cases based on maternal reports at 1-, 6-, 12-, and 24- months after birth. AhR activity (pg 2,3,7,8-TCDD equivalent (TEQ)/g lipid) was determined by DR- CALUX ® assay in samples of mothers’ milk collected a month after delivery. We used multivariate logistic regression to compare AhR activity levels between cases and controls , and we used linear regression to study the association between 27 potential EDCs and AhR activity.Results : The average estimated daily intake (EDI) of dioxin and dl-compounds via breast milk is 33.7 ± 17.9 pg TEQ/kg bodyweight per day among Norwegian children. There were no significant differences in AhR activation in breast milk samples between cases with cryptorchidism and controls. Among the 27 chemicals measured in breast milk, AhR activity was (borderline) significantly associated with all dioxin-like (dl)-PCBs, three non-dioxin-like (ndl)-PCBs (PCB-74, PCB-180, PCB-194) and two organochlorine pesticides (HCB, β-HCH). No associations was observed between AhR activity and brominated flame-retardants (PBDEs) or poly- and perfluoroalkyl substances (PFASs).Conclusion : No association between AhR activity and cryptorchidism was found in this study among Norwegian boys. The average EDI of dioxin and dl-compounds in exclusively breastfed Norwegian infants remains above the safety threshold and, therefore requires further reduction measures.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessAryl Hydrocarbon Receptor Activity in Human Breast Milk and Cryptorchidism. A Casecontrol Study within the Prospective Norwegian Humis Cohort
Background : The aetiology of cryptorchidism remains poorly understood. Exposure to specific endocrine disrupting chemicals are associated with cryptorchidism. A potential mechanism of EDCs may be by impacting estrogen signaling by interacting with aryl hydrocarbon receptor (AhR) activity.Objective : To evaluate whether AhR activity in mothers milk samples is associated with offspring cryptorchidism.Method : We conducted a case-control study based on 199 mother-child pairs (91 cases/108 controls) selected from the prospective Norwegian birth cohort HUMIS, recruited in 2002-2009. We defined cases based on maternal reports at 1-, 6-, 12-, and 24- months after birth. AhR activity (pg 2,3,7,8-TCDD equivalent (TEQ)/g lipid) was determined by DR- CALUX ® assay in samples of mothers’ milk collected a month after delivery. We used multivariate logistic regression to compare AhR activity levels between cases and controls , and we used linear regression to study the association between 27 potential EDCs and AhR activity.Results : The average estimated daily intake (EDI) of dioxin and dl-compounds via breast milk is 33.7 ± 17.9 pg TEQ/kg bodyweight per day among Norwegian children. There were no significant differences in AhR activation in breast milk samples between cases with cryptorchidism and controls. Among the 27 chemicals measured in breast milk, AhR activity was (borderline) significantly associated with all dioxin-like (dl)-PCBs, three non-dioxin-like (ndl)-PCBs (PCB-74, PCB-180, PCB-194) and two organochlorine pesticides (HCB, β-HCH). No associations was observed between AhR activity and brominated flame-retardants (PBDEs) or poly- and perfluoroalkyl substances (PFASs).Conclusion : No association between AhR activity and cryptorchidism was found in this study among Norwegian boys. The average EDI of dioxin and dl-compounds in exclusively breastfed Norwegian infants remains above the safety threshold and, therefore requires further reduction measures.
- Open Access
- 1 May 2019
- Published by Elsevier in Computational Toxicology
- Vol. 10, 158-168
Role of Physiologically Based Kinetic modelling in addressing environmental chemical mixtures – A review
- 1 May 2019
- Published by Elsevier in Computational Toxicology
- Vol. 10, 158-168
Open AccessRole of Physiologically Based Kinetic modelling in addressing environmental chemical mixtures – A review
- Top Cited PapersOpen Access
- 1 February 2019
- Published by Elsevier in Computational Toxicology
- Vol. 9, 61-72
Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making
- 1 February 2019
- Published by Elsevier in Computational Toxicology
- Vol. 9, 61-72
Top Cited PapersOpen AccessNext generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making